Untitled

Lab

Events

Events Search and Views Navigation

Event Views Navigation

Today

  • “USP <797>/<800>: Cleanroom Design & Environmental Monitoring”

    Access the recording. Download a copy of this presentation. HealthTrust & TechSafety present..."USP <797>/<800>: Cleanroom Design & Environmental Monitoring" While USP (United States Pharmacopeia) <797> previously established requirements for hazardous drug compounding, its latest revision—<800>—clarifies and expands upon sterile and non-sterile hazardous drug compounding. Enhanced engineering and procedural controls extend protection to operators and environments […]

  • “Innovation in Sepsis Diagnostics & Treatment”

    The Sepsis Coordinator Network * presents..."Innovation in Sepsis  Diagnostics & Treatment" Learn about some of the latest innovations in sepsis diagnostics and treatment. Objectives: Discuss the role that fast diagnostics for bloodstream infections play in expediting treatment of patients. Define the role of GIAPREZA in treating patients with septic or other distributive shock Recall patient-focused […]

  • “Infectious Waste DOT Certification”

    Daniel's Health* presents..."Infection Waste DOT Certification" Did you know that anyone who is packaging or transporting waste within a healthcare facility is required to be certified for DOT RMW Training?  Attend this free session for DOT certification on Infectious Substances. Learning Objectives | At the completion of this activity, the participant will be able to: […]

  • “High Reliability & Safety in Obstetrics: A Life-saving Approach”

    Access the recording. Download a copy of this content. Supporting Documents & Procedure Checklists HealthTrust presents..."High Reliability & Safety in Obstetrics: A Life-saving Approach" (Part 1 of 4 in the Maternal Morbidity & Mortality series) The proportion of women who experienced serious complications while giving birth in U.S. hospitals rose drastically between 2006 and 2015. […]

  • “Implementing Next-generation Sequencing for Precision Oncology Testing”

    Fisher Scientific* presents...."Implementing Next-generation Sequencing for Precision Oncology Testing" According to a recent study by the Tufts Center for the Study of Drug Development, the majority of cancer treatments in development have an associated genomic biomarker—a trend that's expected to increase in the coming years. With this evolution in the clinical oncology landscape, academic medical […]

  • “How I Recommend Flu Vaccine: How to Make Recommendations that Matter to Patients”

    The CDC & the Public Health Foundation* present…“How I Recommend Flu Vaccine: How to Make Recommendations that Matter to Patients” Every year, there are large numbers of Americans who get sick and die as a result of seasonal flu. Yet, many of your patients may underestimate flu’s severity or their own susceptibility to catching the […]

  • 2019 HTU Call for Proposals Is Open

    Speakers are invited to submit proposals for consideration as part of the 2019 HealthTrust University Conference education line up. Submit proposals here by the Jan. 14 deadline (11:59 PM central time). Invite others from your facility or health system to share their clinical initiative outcomes or supply chain success stories. Download a flyer to share […]

  • “Code Crimson: Massive Transfusion Protocol”

    Access the recording. Download a copy of this content. Supporting Documents & Procedure Checklists HealthTrust presents..."Code Crimson: Massive Transfusion Protocol" (Part 2 of 4 in the Maternal Morbidity & Mortality series) The U.S. rate of severe maternal morbidity at delivery, as defined by a variety of conditions and procedures, increased 45 percent from 2006 through […]

  • Deadline for 2019 HTU Proposals

    Tonight is the deadline to submit presentations for consideration as part of the 2019 HealthTrust University Conference education line up. Submit proposals here by 11:59 PM (Central time). 2019 HTU: August 12-14  |  Gaylord Opryland Resort & Convention Center  |   Nashville, TN  

  • “Consequences of FDA Changes to Critically Ill Bedside Glucose Testing Regulations”

    Nova Biomedical* presents… “Consequences of FDA Changes to Critically Ill Bedside Glucose Testing Regulations” Part I: Clinical Consequences  |  “Venous, arterial, and now capillary specimens are all FDA cleared for testing critically ill patients – Are all specimen types analytically and clinically equivalent?” The choice of specimen type is an important consideration, particularly for critically ill […]